ImmuneOncia aims to develop immuno-oncology therapeutics

to transform the standard of care in cancer treatment

  • IR/PR
  • Disclosures

Disclosures

Submission Date Disclosure Title Author
2025-05-12 Post-issuance report 이뮨온시아
2025-04-30 [Corrected description]Prospectus 이뮨온시아
2025-04-30 [Conditions for issuance finalized]Registration Statement (Equity securities) 이뮨온시아
2025-04-28 Prospectus 이뮨온시아
2025-04-18 [Corrected description]Registration Statement (Equity securities) 이뮨온시아
2025-04-17 [Corrected description]Registration Statement (Equity securities) 이뮨온시아
2025-04-04 [Corrected attachment]Registration Statement (Equity securities) 이뮨온시아
2025-04-04 [Corrected description]Registration Statement (Equity securities) 이뮨온시아
2025-04-02 [Corrected description]Registration Statement (Equity securities) 이뮨온시아
2025-03-28 Audit report (2024.12) 삼일회계법인
1 2 3 4 5